Note: Cancer IQ's revenues are gauged from an analysis of company filings.
Cancer IQ's Income Statement (based on Industry Averages)
Cancer IQ P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Cancer IQ has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
November 13, 2023
9
56%
$6 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Cancer IQ is developing and marketing.
Cancer IQ doesn't have any recent trademark applications, indicating Cancer IQ is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
CANCERIQ Providing a website featuring on-line non-downloadable software for organization, management and sharing of data related to cancer research, namely, epidemiology surveys, clinical records, pathology reviews, radiology exams, and bio-specimen banks, allows the upload and viewing of pictures and video, for use in the medical field and clinical research; Providing temporary use of on-line non-downloadable cloud computing software for organization, management and sharing of data related to cancer research, namely, epidemiology surveys, clinical records, pathology reviews, radiology exams, and bio-specimen banks, allows the upload and viewing of pictures and video, for use in the medical field and clinical research
11/03/2014
CANCERIQ RISK Cloud-based, non-downloadable computer software in the field of healthcare for use in managing cancer risk assessment; Cloud-based, non-downloadable computer software in the field of healthcare for controlling, analyzing and managing patient medical information
06/10/2014
See all trademarks and details in the Full Report.
Market Share of Cancer IQ's Largest Competitors
A competitive analysis shows these companies are in the same general field as Cancer IQ, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Cancer IQ.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Cancer IQ's Fastest Growing Competitors
These companies are in the same general field as Cancer IQ and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.